Breast Cancer Clinical Trial
Stress, Diurnal Cortisol, and Breast Cancer Survival
Summary
The purpose of this study is to learn about the effects of stress on hormones, the relationship between these hormones and cancer progression.
Full Description
The purpose of this study is to investigate stress and tonic activation of diurnal cortisol in aging metastatic breast cancer patients; feedback inhibition & activation of cortisol; and stress-induced phasic activation of cortisol.
Eligibility Criteria
Inclusion Criteria:
Diagnosis of recurrent or metastatic breast cancer.
Karnofsky of 70% or greater.
Proficient enough in English to be able to take questionnaires and participate in the required tasks.
Living within the Greater Bay Area.
Age 35 or older .
Exclusion Criteria:
Positive supraclavicular lymph nodes as the only metastatic lesion at the time of initial diagnosis.
Active cancers within the past 10 years other than breast cancer, basal cell or squamous cell carcinomas of the skin, or in situ cancer of the cervix.
Any other serious medical condition that will effect short term survival
History of major psychiatric illness for which patient was hospitalized or medicated, with the exception of depression or anxiety
A diagnosis of diabetes.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Stanford California, 94305, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.